Govt Rajaji Hospital tops TN in blood donation
Tired of too many ads? go ad free now
Doctors said the hospital has been able to manage 100% of the patients' needs for blood over the past year, thanks to donors from different walks of life, from colleges to organisations.
Dr M Sintha, head of the Department of Immunohematology and Transfusion Medicine, said the blood bank has been selected for an award at national level. "The blood collected is 100% screened and analysed. The hospital has also identified as many as 29 rare 'O' negative and 'Bombay' blood group donors.
We are constantly in touch with them for any urgent blood requirements," she added. A total of 208 blood donation camps were organised by GRH last year.
Apart from large amounts of donated blood being used for treatment during bleeding in pregnancy cases, emergency trauma cases, and surgeries, the donated blood is also used for treating blood disorders like thalassemia. "After the Covid-19 pandemic, a fear to donate blood was prevalent among people.
But, with awareness, the attitude is changing," said A Rajkumar, district secretary, Indian Red Cross Society (IRCS), Madurai.
While student donors were common, they were trying to work with private companies to conduct blood donation camps,. he said.
GRH alone needs more than 100 units of blood every day. Many people are keen to donate when they come to know that donating blood is a sign of good health and does them no harm, said Rajkumar who has donated blood 54 times so far.
Tired of too many ads? go ad free now
GRH dean Dr L Arul Sundaresh Kumar on Saturday felicitated colleges whose student volunteers donated most units of blood to the blood bank in 2024. The first prize was won by The American College student volunteers who donated 1,223 units of blood, followed by volunteers of NMSS Vellaichamy Nadar College, and Thiagarajar Engineering College. Volunteer blood donors through fan clubs of popular Tamil film actors or political organisations have also come forward for blood donations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
Strengthen RBSK to provide better care for children: Mysuru ZP CEO
Zilla Panchayat Chief Executive Officer S. Yukesh Kumar has directed officials to strengthen the Rashtriya Bal Swasthya Karyakram (RBSK) and ensure better medical care for children of Anganwadis and schools who are suffering from health issues. At a district-level review meeting of national health programmes, Mr. Kumar instructed officials to conduct regular health screenings at schools and Anganwadis to identify diseases at an early stage and provide timely treatment. 'Children with heart ailments must be provided with specialised treatment and surgeries at superspecialty hospitals to help reduce infant mortality,' he said. Mr. Kumar said that follow-up and completion of treatment for children referred for further care must be ensured and called for necessary action based on reports from the district-level technical expert committee in cases of maternal and infant deaths to identify lapses and initiate action against those responsible. He instructed officials to achieve 100% targets under the Kayakalpa scheme in the financial year 2025-26, and directed all health centres to reach 100% progress in the next three months. Mr. Kumar stressed the importance of strict biomedical waste disposal at Ayushman Arogya Mandirs as per government guidelines and added that cases of Covid-19, Influenza H1N1, dog bites, and snake bites must be mandatorily reviewed with appropriate action taken. He directed officials to bring down the TB death rate to below 5%, expedite leprosy surveys, and report all suspected cases immediately. Mr. Kumar instructed that Manochaitanya counselling centres should operate every Tuesday, and photos of activities should be filed for documentation. Officials from District Health and Family Welfare Departments, including RCH officers, TB control officers, leprosy eradication officers, vector-borne disease control officers, surveillance officers, and taluk medical officers attended the meeting.
Hans India
5 hours ago
- Hans India
CM Revanth Reddy Launches Icore Biologics Industry in Genome Valley
In a significant move for the biotechnology sector, Chief Minister Revanth Reddy visited Samirpet's Genome Valley to lay the foundation stone for the Icore Biologics Industry. The event was attended by Ministers Sridhar Babu and Vivek, along with senior officials and various stakeholders. Speaking at the ceremony, CM Reddy highlighted the crucial role that the Genome Valley has played in establishing Telangana as a leader in the biotechnology industry. "The industries in Genome Valley have brought recognition to Telangana. We produce 33 percent of the country's vaccine production from Genome Valley alone. At a time when the world was gripped by fear of Covid-19, we manufactured vaccines here and were able to supply them to countries around the world," he stated. The establishment of Icore Biologics is expected to further strengthen Telangana's position in the global biotech arena and enhance its contributions to vaccine development and production.
The Hindu
5 hours ago
- The Hindu
AIC-CCMB planning trials for Chikungunya vaccine with indigenously developed mRNA technology
CSIR-Centre for Cellular and Molecular Biology (CCMB) Atal Incubation Centre (AIC) is planning to go ahead with the next stage larger-scale trials of the indigenously developed mRNA vaccine technology for tackling Chikungunya. 'Chikungunya is a serious, major debilitating disease in India and it does not yet have a vaccine. We have already demonstrated the ability to make use of mRNA technology to develop vaccines with a 'Proof of Concept' (PoC) during the COVID-19 pandemic. Our lab data trials show our Chikungunya vaccine works,' disclosed AIC-CCMB chief executive officer N. Madhusudhana Rao. Results of lab experiments The lab experiments conducted on animals showed that the vaccine candidate can produce antibodies against Chikungunya proteins. The next phase will be to infect the animals and check if the virus load has decreased upon injecting the developed vaccine, he explained. The CEO said the institute had also completed initial trials into a potential mRNA vaccine to prevent tuberculosis (TB). But, to go into the next stage of animal trials and more elaborate testing, adequate funding is required, for which different options are being explored. How vaccines work? Vaccines work by preparing and training the immune system to identify disease-causing microorganisms and eliminate them quickly when the system encounters them. In mRNA technology, the host cell's immune system is trained to evade the real infection by introducing mRNA of an important protein of the microorganism of concern into the host, said Mr. Rao. Interestingly, though AIC had developed the PoC for mRNA technology in less than a year and had announced the same two years ago, it did not elicit much response from either the Indian industry or foreign collaborators. 'There were a few firms which evinced interest in making use of our mRNA technology for vaccine research. But they never came back with concrete proposals. It is an accepted fact that firms spend millions to take licenses from abroad rather than spend a few lakhs on local technology,' said Mr. Rao, a former senior scientist of the CSIR-CCMB. Comirnaty (by Pfizer) or Spikevax (by Moderna) are based on mRNA technology for COVID and found to be extremely effective. The mRNA technology is considered chemically safe with no long-term challenges. The one developed in AIC-CCMB too is based on the existing mRNA vaccine model. It is as safe as the one approved by the US Food & Drug Administration Agency and had undergone a third party quality check, affirmed the CEO. mRNA works much better on viruses and vaccines can be developed for other diseases faster. 'It is unfortunate that there are few takers for our technology, though many are trying the same through different platforms. But we want to go ahead with our trials for the potential Chikungunya and TB vaccine candidates now with different partners,' added Mr. Rao.
